IPP Bureau
Venus Remedies sends humanitarian aid to Ukraine
By IPP Bureau - May 05, 2022
The company dispatched the first batch of essential medicines worth US $ 30,000 to Ukraine through its embassy in New Delhi
Avantor to create a new manufacturing hub in Singapore
By IPP Bureau - May 05, 2022
The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year
Evonik opens its first Zero Liquid Discharge plant in India
By IPP Bureau - May 05, 2022
Evonik in association with Remondis has opened its first plant in India to ensure Zero Liquid Discharge. It is located at Dombivli in Western Maharashtra
Israeli researchers warn about the return of Delta variant
By IPP Bureau - May 05, 2022
The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.
DNA Script partners with Premas Life Sciences for same-day enzymatic DNA synthesis
By IPP Bureau - May 05, 2022
This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
Siemens Healthineers achieves milestone of producing 500 units of Cios Fit in India
By IPP Bureau - May 05, 2022
Conceptualized, designed, and manufactured in India for the world, Cios Fit is a mobile C-arm designed for demanding multidisciplinary environments in busy operating rooms
Merck invests $110 million to expand production site in China
By IPP Bureau - May 05, 2022
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021
By IPP Bureau - May 05, 2022
The report has estimated 4.74 million deaths for India in 2020 and 2021,
HPRA completes audit of Biocon Biologics New mAbs drug substance facility
By IPP Bureau - May 04, 2022
The inspection report contains no 'critical' observations and only one of the deficiencies is categorized as 'major' which is being addressed expeditiously in consultation with the regulatory agency
Eugia Pharma receives USFDA approval for Bortezomib
By IPP Bureau - May 04, 2022
The approved product has a market size of US $ 1172 million for the twelve months ending March 2022, according to IQVIA
Alkem launches Innohaler for asthma & COPD patients
By IPP Bureau - May 04, 2022
With the introduction of this device, Alkem is entering the core inhalation therapeutics and envisaging that the drug will reach the lungs effectively in each inhalation with added patient awareness and adherence programmes
Scipio bioscience announces its revolutionary Asteria single-cell RNA-seq kit
By IPP Bureau - May 04, 2022
At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes
.jpg "Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore")
Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore
By IPP Bureau - May 04, 2022
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery
By IPP Bureau - May 04, 2022
The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months
Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India
By IPP Bureau - May 04, 2022
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
